This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tchekmedyian, N. S. Articles by Heber, D. Search for Related Content PubMed PubMed Citation Articles by Tchekmedyian, N. S. Articles by Heber, D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cancer Hazardous Substances DB MEGESTROL Social Bookmarking                         What's this?

Nutrition in Advanced Cancer: Anorexia as an Outcome Variable and Target of Therapy

Pacific Coast Hematology/Oncology Medical Group, Inc, Long Beach, University of California Los Angeles School of Medicine, Diuision of Clinical Nutrition

Cynthia Halpert, RD

Pacific Coast Hematology/Oncology Medical Group, Inc, Long Beach, University of California Los Angeles School of Medicine, Diuision of Clinical Nutrition

Judith Ashley, PHD, RD

University of California Los Angeles School of Medicine, Diuision of Clinical Nutrition

David Heber, MD, PHD

University of California Los Angeles School of Medicine, Diuision of Clinical Nutrition

The endpoints used as outcome variables in clinical cancer treatment trials, including nutrition intervention studies, should contain items that are meaningful to the patient. Variables to consider are appetite, food intake, physical performance, psychological and social functioning, response to cancer therapies, survival time, nutrition status, associated morbidity, and costs. Ideally, the design and conduct of nutrition trials should be carried out by a multidisciplinary team comprising medical oncologists, physician specialists in nutrition, dietitians, and social scientists. Anorexia has not been a focus of nutrition support trials in the past partly because of the lack of effective strategies to reverse it. Anorexia is one important cause of cancer starvation, and it also causes patient discomfort. This paper describes outcome variables that include patient derived subjective factors such as anorexia, and outlines new strategies to reverse anorexia. Pharmacologic strategies tested to reverse anorexia include corticosteroids, anabolic steroids, cyproheptadine, hydrazine sulfate, cannabinoids, and megestrol acetate. Of these, only the latter has been consistently well tolerated and effective, with significant improvements in appetite and food intake demonstrated in large-scale, randomized, controlled trials involving more than 600 cancer patients. Dose-response studies have demonstrated increasing efficacy with increasing doses of megestrol acetate from 160 to 800 mg/day. Doses in excess of 800 mg/day are not currently recommended. The mechanisms of action of megestrol acetate involve both behavioral and metabolic effects, and its impact on energy expenditure, appetite, body composition, endocrine function, and lipid metabolism is the subject of ongoing research. Such effects as well as new information on the role of various cytokines provide opportunities to test new therapies to renourish the cancer patient not by way of forced feeding, but by reversing the systemic effects of malignancies that impair renutrition. (Journal of Parenteral and Enteral Nutrition 16:885-925, 1992)

Journal of Parenteral and Enteral Nutrition, Vol. 16, No. 6 Suppl, 88S-92S (1992)
DOI: 10.1177/014860719201600610


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. Poole and K. Froggatt Loss of weight and loss of appetite in advanced cancer: a problem for the patient, the carer, or the health professional? Palliative Medicine, September 1, 2002; 16(6): 499 - 506. [Abstract] [PDF]

				N. S. Tchekmedyian Treatment of Anorexia With Megestrol Acetate Nutr Clin Pract, June 1, 1993; 8(3): 115 - 118. [Abstract] [PDF]